All In Biotech

Drug Trial Radar · NCT01907087

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease

A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease

Last checked: Nov 20, 2026Latest source record: Mar 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Sep 2013

Primary completion

Nov 2015

Study completion Nov 2015

Sponsor

Lead sponsor
BioMarin PharmaceuticalBioMarin (BMRN)
Sponsor type
Industry
First posted
Jul 24, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 3 years, up to 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether BMN 190 is safe and effective in the treatment of patients with Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) disease.

Conditions

  • Jansky-Bielschowsky Disease
  • Batten Disease
  • Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2
  • CLN2 Disease

Interventions

  • BMN 190Biological

    30-300 mg ICV infusion administered every other week for at least 48 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Motor-Language (ML) Scale Score During 300 mg Dosing PeriodTime frame: Baseline, Week 49/Last Assessment

Locations

5 sites in 4 countries. Site status is shown where the registry gives one.

  • Nationwide Children's Hospital

    Columbus, Ohio

  • University Hamburg-Eppendorf

    Hamburg, Germany

  • Bambino Gesù Children's Hospital

    Rome, Italy

  • Guy's & St. Thomas NHS Foundation Trust

    London, United Kingdom

  • Great Ormond Street Hospital for NHS Foundation Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.